Nomura Securities Upgrades Intercept Pharmaceuticals (ICPT) to Buy; $633 Bull Case
Tweet Send to a Friend
Nomura Securities upgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from Neutral to Buy with a price target of $323.00 (from $294.00).Analyst M ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
